Rice Hall James & Associates’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $226K | Buy |
92,398
+4,879
| +6% | +$12K | 0.01% | 245 |
|
|
2025
Q1 | $584K | Sell |
87,519
-3,315
| -4% | -$22.1K | 0.03% | 213 |
|
|
2024
Q4 | $1.14M | Sell |
90,834
-1,308
| -1% | -$16.4K | 0.06% | 199 |
|
|
2024
Q3 | $1.7M | Buy |
92,142
+16,719
| +22% | +$309K | 0.09% | 188 |
|
|
2024
Q2 | $1.62M | Buy |
75,423
+2,895
| +4% | +$62.3K | 0.1% | 178 |
|
|
2024
Q1 | $1.95M | Buy |
72,528
+100
| +0.1% | +$2.69K | 0.11% | 173 |
|
|
2023
Q4 | $2.17M | Sell |
72,428
-4,961
| -6% | -$149K | 0.13% | 166 |
|
|
2023
Q3 | $1.59M | Sell |
77,389
-1,597
| -2% | -$32.7K | 0.1% | 188 |
|
|
2023
Q2 | $1.57M | Buy |
78,986
+3,311
| +4% | +$65.8K | 0.09% | 191 |
|
|
2023
Q1 | $1.3M | Buy |
+75,675
| New | +$1.3M | 0.07% | 225 |
|